ABEO
Abeona Therapeutics Inc
5.40$
-1.8%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Income Statement
All figures as a percentage of revenue in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | 1996 | 1997 | 1998 | 1999 | 2000 | 2001 | 2002 | 2003 | 2004 | 2005 | 2006 | 2007 | 2008 | 2009 | 2010 | 2011 | 2012 | 2013 | 2014 | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | 100.0% | 100.0% | 100.0% | – | 100.0% | |
| 4,978.4% | 133.3% | – | – | 5,367.3% | 2,523.9% | 9.3% | 21.4% | 43.5% | – | – | 11,715.8% | 2,774.6% | 2,775.3% | 29.1% | 65.8% | 6.1% | 6.1% | 1.2% | 1,830.3% | 1,198.5% | 2,029.7% | 1,290.8% | – | 301.4% | 1,290.9% | 31.8% | 45.9% | – | 26.3% | |
| -4,878.4% | -33.3% | 100.0% | 100.0% | 100.0% | 100.0% | 90.7% | 78.6% | 56.5% | – | 100.0% | 100.0% | 100.0% | 100.0% | 70.9% | 34.2% | 93.9% | 93.9% | 100.0% | 100.0% | -1,098.5% | -1,929.7% | -1,190.8% | – | 100.0% | 100.0% | 68.2% | 54.1% | – | 73.7% | |
| 841.3% | 559.3% | 1,800.0% | 10,720.0% | 3,744.9% | 1,717.7% | 612.4% | 196.8% | 425.3% | – | 0.4% | 4,564.9% | 4,334.4% | 754.8% | 696.3% | 193.7% | 45.6% | 43.3% | 36.0% | 453.4% | 1,198.5% | 2,029.7% | 1,290.8% | – | 301.4% | 1,290.9% | 2,048.4% | 888.3% | – | 460.7% | |
| 1,160.5% | 410.1% | 1,500.0% | 9,806.7% | 1,622.4% | 806.2% | 198.5% | 194.1% | 582.7% | – | 0.5% | 1,678.9% | 1,491.4% | 2,020.5% | 937.8% | 31.5% | 136.8% | 236.7% | 401.3% | 1,376.9% | 1,494.9% | 1,307.4% | 670.6% | – | 237.8% | 721.5% | 1,220.4% | 543.0% | – | 1,117.4% | |
| 2,075.4% | 1,006.7% | 3,500.0% | 22,426.7% | 5,761.7% | 2,695.9% | 849.2% | 497.6% | 1,149.9% | – | 0.9% | 12,205.3% | 5,912.7% | 2,848.9% | 1,634.1% | 447.8% | 191.9% | 280.2% | 438.5% | 1,883.3% | 2,786.3% | 3,425.7% | 2,040.2% | – | 914.2% | 3,094.5% | 3,669.0% | 1,400.9% | – | 1,610.6% | |
| -6,953.9% | -1,040.0% | -3,500.0% | -22,326.7% | -5,661.7% | -2,595.9% | -758.5% | -419.0% | -1,093.4% | – | -0.9% | -12,105.3% | -5,812.7% | -2,748.9% | -1,612.7% | -426.2% | -98.0% | -186.3% | -338.5% | -1,783.3% | -2,686.3% | -3,325.7% | -1,940.2% | – | -814.2% | -2,994.5% | -3,600.8% | -1,346.7% | – | -1,536.9% | |
| 26.9% | 0.0% | 0.0% | 0.0% | 319.6% | 481.5% | 111.4% | 98.9% | 252.3% | – | 1.4% | 6,164.9% | 313.1% | 153.1% | 126.2% | 52.1% | 13.8% | 13.7% | 62.9% | 0.6% | 0.7% | 1.0% | 0.4% | – | 41.2% | 121.9% | 52.1% | 11.9% | – | 64.3% | |
| -6,863.5% | -1,020.9% | – | -22,053.3% | -5,072.9% | -2,480.2% | -818.1% | -496.4% | -1,864.8% | – | -2.4% | -38,450.9% | -5,915.8% | -4,781.3% | -1,566.9% | -136.1% | -239.1% | 217.9% | -2,894.9% | -1,396.7% | -2,460.4% | -3,263.9% | -1,890.3% | – | -842.3% | -2,831.2% | -2,807.4% | -1,548.2% | – | 1,224.8% | |
| -90.4% | -19.1% | – | – | – | – | – | – | – | – | 0.0% | -107.0% | 61.2% | 2,177.3% | -45.7% | 0.9% | 13.8% | 13.7% | 62.9% | 387.1% | 226.5% | 62.7% | 50.2% | – | 41.2% | 122.3% | -557.8% | 86.6% | – | 1.7% | |
| -6,863.5% | -1,020.9% | -3,400.0% | -22,053.3% | -5,072.9% | -2,480.2% | -818.1% | -535.5% | -1,864.8% | – | -2.3% | -38,147.4% | -10,801.0% | -4,926.1% | -1,566.9% | -137.0% | -239.1% | 217.9% | -2,894.9% | -1,396.7% | -2,460.4% | -3,263.9% | -1,890.3% | – | -842.3% | -2,831.2% | -2,807.4% | -1,548.2% | – | 1,223.1% | |
| -6,880.2% | -1,002.8% | -3,300.0% | -20,426.7% | -5,216.8% | -2,337.9% | -698.7% | -349.7% | -897.4% | – | 0.5% | -31,796.5% | -10,449.1% | -2,675.3% | -1,391.3% | -123.5% | -215.8% | 231.7% | -2,830.8% | -1,343.2% | -2,367.6% | -3,175.4% | -1,811.6% | – | -745.2% | -2,560.5% | -2,431.6% | -1,444.9% | – | 1,350.3% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.